BEVERLY–Medicinal Genomics Corporation has received AOAC Research Institute certification for its PathoSEEK Listeria detection assay, a molecular testing system designed to identify potentially dangerous bacterial contamination in food products, dietary supplement ingredients and manufacturing environments.
The company’s PathoSEEK Listeria mono & spp. Multiplex Detection Assay, which uses its MaGiC Lysis technology, earned Performance Tested Methods certification for whey powder, ready-to-eat meats, fresh spinach and several types of environmental surfaces.
The test uses quantitative polymerase chain reaction (qPCR) technology to detect both Listeria species and Listeria monocytogenes in a single reaction. According to the company, the system can provide results the day after sampling for most sample types, allowing food manufacturers to identify contamination more quickly.
The certification covers ready-to-eat deli turkey, hot dogs, fresh bagged spinach, whey powder and surfaces made of stainless steel, ceramic, plastic and sealed concrete.
Independent testing conducted by Q Laboratories evaluated the assay’s accuracy against established methods used by the U.S. Department of Agriculture and the Food and Drug Administration.
The study found that the assay successfully detected all 91 targeted Listeria strains, including 51 strains of Listeria monocytogenes, while correctly excluding 46 organisms that were not intended targets.
Researchers also reported no statistically significant differences between the assay’s performance and established federal culture-based testing methods across the evaluated food products, surfaces and instruments.
The certification comes amid continued concerns about Listeria contamination in the U.S. food supply.
According to the Centers for Disease Control and Prevention, Listeria infections affect approximately 1,600 Americans annually and cause about 260 deaths. The bacterial infection is particularly dangerous because of its high hospitalization and fatality rates.
A 2026 report from the U.S. Public Interest Research Group found that Listeria was responsible for 21 of the 22 deaths associated with U.S. foodborne illness outbreaks in 2025.
Recent outbreaks linked to nutritional shakes, deli meats and prepared pasta products have raised concerns about the time required to identify contamination and remove affected products from distribution.
“Listeria caused nearly every U.S. foodborne outbreak death last year, and the outbreaks keep showing the same pattern: contamination found weeks or months too late,” said Brendan McKernan, CEO of Medicinal Genomics. “Nutritional shakes are part of that story. Certifying whey powder alongside meats, produce, and environmental surfaces adds Listeria to our microbial testing solution for supplements.”
Food manufacturers typically test production surfaces for the broader presence of Listeria species while screening finished products for Listeria monocytogenes, the species responsible for listeriosis.
Many existing molecular testing methods require separate testing kits for each target. Medicinal Genomics said its assay combines both detection processes into a single reaction, potentially reducing laboratory processing time and simplifying testing procedures.
The system also includes an internal control designed to reduce the risk of false-negative results.
An optional certified processing step removes DNA from dead bacterial cells, which could otherwise affect test results following sanitation procedures.
Q Laboratories conducted the independent validation studies required for AOAC certification, including assessments of the test’s ability to detect targeted organisms and distinguish them from unrelated bacteria.
“Rapid methods offer significant advantages by reducing turnaround times, enabling quicker decision-making, and helping food manufacturers identify potential microbiological hazards before products reach consumers. However, speed alone is not enough,” said Ben Bastin, Director of Microbiology Operations at Q Laboratories.
“These methods must be thoroughly validated to demonstrate that they are accurate, reliable, reproducible, and fit for their intended purpose. Robust validation provides confidence that rapid methods perform consistently across different food matrices, processing environments, and testing conditions. The PathoSEEK Listeria method has been validated for select foods and environmental surfaces and compared to the U.S. reference methods. By statistically comparing the rapid method and the reference method, no statistical differences were observed,” Bastin added.
Medicinal Genomics designed the testing platform to support automated laboratory workflows using equipment manufactured by Bio Molecular Systems.
The company’s recommended configuration includes the Myra liquid handler, which can prepare 46 samples in less than 15 minutes, and the Mic qPCR cycler, which completes the molecular analysis in under two hours following sample preparation and enrichment.
For most sample types, the overall testing process includes a 24- to 28-hour enrichment period before molecular analysis.
The assay is also certified for use with Bio-Rad’s CFX96 Touch and CFX Opus instruments, providing additional options for laboratories with existing testing equipment.
Medicinal Genomics said the PathoSEEK Listeria assay is commercially available, expanding its portfolio of microbial testing products for food and dietary supplement manufacturers.
The company expects the certification to support wider adoption of its molecular testing technology among manufacturers seeking faster methods to detect bacterial contamination and strengthen food safety monitoring.


